Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 14 | 2017 | 195 | 1.750 |
Why?
|
| Monocytes | 7 | 2021 | 132 | 1.590 |
Why?
|
| Cholesterol | 12 | 2020 | 255 | 1.580 |
Why?
|
| Inflammation | 9 | 2022 | 542 | 1.300 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2020 | 57 | 1.240 |
Why?
|
| ATP-Binding Cassette Transporters | 6 | 2013 | 60 | 1.170 |
Why?
|
| Energy Metabolism | 2 | 2020 | 156 | 1.110 |
Why?
|
| Signal Transduction | 7 | 2020 | 689 | 0.910 |
Why?
|
| Atherosclerosis | 9 | 2020 | 801 | 0.910 |
Why?
|
| Mice | 29 | 2022 | 2528 | 0.840 |
Why?
|
| Lipoproteins, HDL | 7 | 2015 | 254 | 0.790 |
Why?
|
| Animals | 33 | 2022 | 7598 | 0.710 |
Why?
|
| Membrane Microdomains | 5 | 2015 | 21 | 0.700 |
Why?
|
| Pyruvate Dehydrogenase Complex | 2 | 2022 | 18 | 0.670 |
Why?
|
| Succinates | 1 | 2020 | 6 | 0.630 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 11 | 0.630 |
Why?
|
| Liver | 7 | 2017 | 492 | 0.630 |
Why?
|
| Apolipoprotein A-I | 7 | 2015 | 67 | 0.600 |
Why?
|
| Fatty Acids, Omega-6 | 2 | 2017 | 31 | 0.560 |
Why?
|
| Toll-Like Receptors | 3 | 2015 | 24 | 0.550 |
Why?
|
| Mice, Inbred C57BL | 13 | 2017 | 790 | 0.550 |
Why?
|
| Autophagy | 2 | 2017 | 55 | 0.540 |
Why?
|
| Dietary Fats | 2 | 2017 | 109 | 0.530 |
Why?
|
| Aging | 3 | 2020 | 945 | 0.500 |
Why?
|
| Mice, Knockout | 12 | 2020 | 458 | 0.500 |
Why?
|
| Receptors, LDL | 9 | 2020 | 66 | 0.490 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2010 | 16 | 0.480 |
Why?
|
| Lipopolysaccharides | 7 | 2020 | 115 | 0.480 |
Why?
|
| Myeloid Cells | 2 | 2014 | 39 | 0.470 |
Why?
|
| Insulin Resistance | 4 | 2017 | 469 | 0.420 |
Why?
|
| Apolipoproteins | 5 | 2015 | 200 | 0.390 |
Why?
|
| Listeria monocytogenes | 1 | 2012 | 8 | 0.380 |
Why?
|
| Hematopoiesis | 1 | 2012 | 33 | 0.370 |
Why?
|
| Lipid Metabolism | 4 | 2019 | 105 | 0.350 |
Why?
|
| Hepatocytes | 3 | 2017 | 83 | 0.330 |
Why?
|
| Carnitine | 2 | 2020 | 14 | 0.310 |
Why?
|
| Principal Component Analysis | 2 | 2020 | 68 | 0.300 |
Why?
|
| Metabolome | 2 | 2020 | 39 | 0.300 |
Why?
|
| Cytokines | 5 | 2020 | 247 | 0.300 |
Why?
|
| Amino Acids | 2 | 2020 | 46 | 0.300 |
Why?
|
| Mitochondria | 3 | 2022 | 209 | 0.300 |
Why?
|
| Obesity | 3 | 2013 | 1179 | 0.290 |
Why?
|
| Cysteine | 2 | 2008 | 138 | 0.270 |
Why?
|
| Apolipoproteins E | 4 | 2013 | 87 | 0.220 |
Why?
|
| Sphingosine | 2 | 2015 | 13 | 0.220 |
Why?
|
| Lysophospholipids | 2 | 2015 | 24 | 0.210 |
Why?
|
| Cells, Cultured | 5 | 2015 | 821 | 0.210 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 1152 | 0.210 |
Why?
|
| Macrophages, Peritoneal | 2 | 2014 | 18 | 0.210 |
Why?
|
| Plant Oils | 2 | 2015 | 17 | 0.210 |
Why?
|
| Interleukin-1beta | 3 | 2020 | 40 | 0.200 |
Why?
|
| Humans | 17 | 2022 | 32952 | 0.200 |
Why?
|
| Sepsis | 2 | 2022 | 166 | 0.200 |
Why?
|
| Fatty Acids | 3 | 2020 | 101 | 0.200 |
Why?
|
| Chemokines | 2 | 2013 | 33 | 0.190 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2022 | 30 | 0.190 |
Why?
|
| Pyruvic Acid | 1 | 2022 | 7 | 0.190 |
Why?
|
| Aortic Diseases | 2 | 2013 | 62 | 0.180 |
Why?
|
| Endothelium, Vascular | 3 | 2012 | 156 | 0.170 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 267 | 0.170 |
Why?
|
| Male | 12 | 2020 | 19743 | 0.170 |
Why?
|
| Enzyme Activation | 3 | 2017 | 133 | 0.170 |
Why?
|
| NF-kappa B | 3 | 2010 | 83 | 0.170 |
Why?
|
| Glycolysis | 1 | 2020 | 20 | 0.160 |
Why?
|
| Gene Deletion | 4 | 2017 | 65 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 26 | 0.160 |
Why?
|
| Lipids | 2 | 2020 | 230 | 0.160 |
Why?
|
| Diet, Atherogenic | 3 | 2015 | 61 | 0.160 |
Why?
|
| Ketones | 1 | 2020 | 11 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2021 | 197 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 1015 | 0.160 |
Why?
|
| Caspase 1 | 2 | 2017 | 6 | 0.160 |
Why?
|
| NAD | 1 | 2019 | 27 | 0.150 |
Why?
|
| Transcription Factor RelB | 1 | 2019 | 26 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 37 | 0.150 |
Why?
|
| Immune Tolerance | 1 | 2019 | 70 | 0.150 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2009 | 14 | 0.150 |
Why?
|
| Nucleotides | 1 | 2019 | 16 | 0.150 |
Why?
|
| Carbohydrate Metabolism | 1 | 2019 | 17 | 0.150 |
Why?
|
| Aorta | 3 | 2015 | 127 | 0.140 |
Why?
|
| Antioxidants | 2 | 2010 | 116 | 0.130 |
Why?
|
| Lipogenesis | 1 | 2017 | 18 | 0.130 |
Why?
|
| Algorithms | 1 | 2020 | 517 | 0.120 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 259 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2010 | 43 | 0.120 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 102 | 0.120 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2015 | 8 | 0.120 |
Why?
|
| Hypertension | 1 | 2022 | 983 | 0.120 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 12 | 0.110 |
Why?
|
| Spleen | 2 | 2013 | 85 | 0.110 |
Why?
|
| Cholesterol Esters | 1 | 2015 | 36 | 0.110 |
Why?
|
| Female | 7 | 2020 | 20363 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2015 | 36 | 0.110 |
Why?
|
| Protein Sorting Signals | 1 | 2015 | 6 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2015 | 97 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2015 | 61 | 0.110 |
Why?
|
| Fatty Acid Desaturases | 1 | 2015 | 49 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 117 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 74 | 0.110 |
Why?
|
| Proteomics | 1 | 2015 | 102 | 0.110 |
Why?
|
| Fish Oils | 2 | 2015 | 35 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2015 | 246 | 0.100 |
Why?
|
| Lipocalins | 1 | 2013 | 7 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 155 | 0.100 |
Why?
|
| Apoptosis | 2 | 2012 | 363 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2015 | 251 | 0.100 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 6 | 0.100 |
Why?
|
| Mice, Obese | 1 | 2013 | 24 | 0.100 |
Why?
|
| Epididymis | 1 | 2013 | 9 | 0.100 |
Why?
|
| Vasculitis | 1 | 2013 | 24 | 0.100 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2003 | 3 | 0.100 |
Why?
|
| Diamide | 2 | 2003 | 3 | 0.100 |
Why?
|
| Lipoproteins | 1 | 2013 | 87 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2012 | 25 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2012 | 22 | 0.090 |
Why?
|
| Thymus Gland | 1 | 2012 | 16 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 255 | 0.090 |
Why?
|
| Recombinant Proteins | 3 | 2010 | 248 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 837 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2012 | 59 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 123 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2012 | 290 | 0.090 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 100 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2012 | 138 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2012 | 187 | 0.080 |
Why?
|
| Apolipoproteins A | 2 | 2008 | 26 | 0.080 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 7 | 0.080 |
Why?
|
| Protein Transport | 1 | 2010 | 72 | 0.080 |
Why?
|
| Cholesterol, VLDL | 3 | 2015 | 11 | 0.080 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2009 | 2 | 0.080 |
Why?
|
| Mutation | 3 | 2010 | 499 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2012 | 604 | 0.080 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2009 | 26 | 0.080 |
Why?
|
| Carotid Artery Diseases | 1 | 2010 | 116 | 0.080 |
Why?
|
| Circular Dichroism | 2 | 2006 | 31 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 2195 | 0.070 |
Why?
|
| beta-Cyclodextrins | 1 | 2008 | 4 | 0.070 |
Why?
|
| Endotoxemia | 1 | 2008 | 7 | 0.070 |
Why?
|
| Kinetics | 2 | 2006 | 206 | 0.070 |
Why?
|
| Kringles | 1 | 2008 | 1 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 65 | 0.070 |
Why?
|
| Lipid Peroxidation | 2 | 2005 | 32 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 30 | 0.070 |
Why?
|
| Biological Transport | 3 | 2013 | 68 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2008 | 39 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 80 | 0.070 |
Why?
|
| Lipoproteins, LDL | 2 | 2021 | 80 | 0.060 |
Why?
|
| Lipoprotein Lipase | 1 | 2006 | 14 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 392 | 0.060 |
Why?
|
| Rats | 2 | 2022 | 1610 | 0.060 |
Why?
|
| Lipoxygenase | 1 | 2005 | 1 | 0.060 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 2005 | 5 | 0.060 |
Why?
|
| Gene Expression | 2 | 2006 | 336 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 36 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2005 | 48 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2005 | 78 | 0.060 |
Why?
|
| Plasmids | 1 | 2005 | 46 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 52 | 0.060 |
Why?
|
| Peptides | 1 | 2005 | 126 | 0.050 |
Why?
|
| Echium | 2 | 2015 | 11 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 213 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 622 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2014 | 66 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 599 | 0.050 |
Why?
|
| Cholesterol, LDL | 2 | 2014 | 173 | 0.050 |
Why?
|
| Rats, Inbred SHR | 1 | 2022 | 32 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 30 | 0.050 |
Why?
|
| Cholesterol, Dietary | 2 | 2013 | 36 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2022 | 31 | 0.050 |
Why?
|
| Acetates | 1 | 2022 | 12 | 0.050 |
Why?
|
| Immunity, Innate | 2 | 2015 | 76 | 0.050 |
Why?
|
| Ceramides | 2 | 2012 | 11 | 0.050 |
Why?
|
| Neutrophils | 2 | 2013 | 110 | 0.050 |
Why?
|
| Fibrosis | 1 | 2022 | 125 | 0.050 |
Why?
|
| Fatty Liver | 2 | 2015 | 66 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 101 | 0.040 |
Why?
|
| Carbon | 1 | 2021 | 11 | 0.040 |
Why?
|
| Myocardium | 1 | 2022 | 192 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 164 | 0.040 |
Why?
|
| Teichoic Acids | 1 | 2019 | 8 | 0.040 |
Why?
|
| Cell Wall | 1 | 2019 | 7 | 0.040 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 727 | 0.040 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2019 | 13 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 20 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2012 | 85 | 0.040 |
Why?
|
| Endotoxins | 1 | 2019 | 37 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2019 | 78 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2019 | 163 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2010 | 241 | 0.040 |
Why?
|
| Cognition | 1 | 2019 | 553 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 20 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 2015 | 8 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 13 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 24 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 21 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 22 | 0.030 |
Why?
|
| gamma-Linolenic Acid | 1 | 2015 | 10 | 0.030 |
Why?
|
| Ligands | 1 | 2015 | 78 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 45 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 72 | 0.030 |
Why?
|
| Proteome | 1 | 2015 | 41 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 287 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 101 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 356 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 319 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 265 | 0.030 |
Why?
|
| Particle Size | 1 | 2013 | 47 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2013 | 39 | 0.030 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2013 | 38 | 0.030 |
Why?
|
| Bile | 1 | 2013 | 7 | 0.030 |
Why?
|
| Animal Feed | 1 | 2013 | 17 | 0.020 |
Why?
|
| Foam Cells | 1 | 2013 | 14 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 229 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 2013 | 46 | 0.020 |
Why?
|
| Feces | 1 | 2013 | 43 | 0.020 |
Why?
|
| Chemokine CCL4 | 2 | 2003 | 4 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 178 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2012 | 6 | 0.020 |
Why?
|
| Sphingomyelins | 1 | 2012 | 7 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 731 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 436 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2012 | 9 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 220 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 95 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2012 | 129 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2003 | 500 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 129 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 79 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 15 | 0.020 |
Why?
|
| Apolipoprotein B-100 | 1 | 2009 | 10 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 50 | 0.020 |
Why?
|
| Stem Cells | 1 | 2012 | 314 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 58 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2008 | 29 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 40 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2008 | 61 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 563 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 74 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 469 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 122 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 106 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 290 | 0.020 |
Why?
|
| Lung | 1 | 2008 | 268 | 0.020 |
Why?
|
| Cattle | 1 | 2006 | 108 | 0.020 |
Why?
|
| Protein Binding | 1 | 2006 | 201 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 222 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Sulfhydryl Reagents | 1 | 2003 | 6 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2003 | 13 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2003 | 22 | 0.010 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2002 | 15 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 124 | 0.010 |
Why?
|